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muscle cells with cunditloned media for 24 hours; osteopontin mRNA was not 
detected in VSMC at baseline. These data suggest hat macrophoge-smooth 
muscle cell interactions are responsible for the coil proliferation and matrix 
production associated with coronary artery disease. 
~ Enzyme Independent Formation of Nitric Oxide Is 
Triggered During Myocardial Ischemla and Results 
in Post Is©heroic Injury 
Jay L. Zweier, Penghai Wang, Nexandre Sarnouilov, 
Pedannan Kuppusamy. The Johns Hopkins Medical Institutions, Baltimore, 
Maryl~'~d 21224 
We have recenfly shown that NO" generation is greatly increased in ischemic 
tissues and results in cellular injury. While it has been generally assumed that 
the formation of NO" in biological tissues is solely due to direct synthesis by 
specific nitric oxide synthase enzymes (NOS), we observe that in ischemic 
tissues such as the heart, large quantities ot NO- can be formed by a mech- 
anism which is not enzyme dependent. Electron paramagneflc resonance, 
EPR, spectroscopy was applied to directly measure the mechanisms of NO" 
generation in the iechemic heart. NO" bound to either intrinsic heine proteins 
or to the spin trap Fe-MGD gives dse to charastedstic triplet signals which 
enable definitive measurement of NO" formed within the head. While only 
trace NO" triplet signals were seen pdor to ischemia, dudng ischemia these 
signals greatly increased indicating that marked NO" generatien occurred. 
White with short ischemic durations of 30 min or less, inhibition of NOS 
decreased NO" formation, inhibition was incomplete and with increasing du- 
rations of iechemia less that 50°/= inhibition was seen. When hearts were 
labeled with lSN nitrite and then subjected Io ischemia prominent doublet 
signals were observed arising from the lSN coupling to the unpaired electron, 
demonstrating that during ischemia nitdte was directly reduced giving rise to 
large amounts of NO*. With long penods of ischemia progressing to necrosis 
this mechanism of NO" formation predominated and it was further observed 
that this NO* generation resulted in myocaroiial injury with a less oi contra~le 
function. The existence of this enzyme independent mechanism of NO" for- 
malign has important implications in our understanding of the pathogenesis 
and treatment of tissue injury. 
~ Selective Activation of the Endothelin-B Receptor: 
Regional Vascular Act ions in Vivo 
Todd E. Rasmussen, Michihisa Jougasaki. Thanom Supapom, John 
C. Bumett Jr.. Cardiorenal Research Laboratory. Mayo Clinic. Rochester, 
Mn 
Eodothelin-1 is a potent vasoconstdctor peptide which exerts its a~ons 
through two distinct receptor subtypes, the Endothelin-A (ET-A) and Endothefin- 
B (ET-B) receptors. Studies demonstrate that the ETA receptor is expressed 
in vascular smooth muscle and activation results in vasoconstriction. The 
ET-B receptor is present on endothelial colts as well as smooth muscle ceils. 
Controversy exists as to the action of the ET-B receptor upon regional vas- 
cular tone. The current study was designed to assess the in vivo activity of 
selective ET-B receptor activation with sarafotoxin on regional circulations at 
paracdne (5 ng/kg/min), pathophysiologic (25 ng/kg/min) and pharmacologic 
(50 og/kg/min) doses in the normal dog (N = 5). 
Baset(ne 5 n 9 25 ng S0 ng 
SVR, RU S0±3 304-3 3S:J:3 56 :t:6* 
PVR, RU 3.6 ± 0.43 3.9 ~:0.5' 4.7 :t: 0.6 5.74-0.8" 
CVR, RU 2.8 :k 1.2 1.6 :i: 0.4 1.84- 0,3 2.1 4- 0.7 
RVR, RU 0.4 4- 0.06 0A :t: 0.03 0.4 =t: 0.02 0.5 :l: 0.06" 
• p < 0.05 vs Baseline 
In addition, co-administration f a sefective ETA receptor antagonist, FR- 
139317 (10 ~g/kg/min), was performed (N = 4) to exclude co-activation 
of the ET-A receptor by sarafotoxin. Co-administration failed to alter the 
vascular response to sarafotoxin. These results demonstrate that selective 
activation of the ET-B receptor at paracdne and pathophysiologic doses 
results in no vassconstdction with a tendency to decrease coronary vascular 
resistance. However, pharmacologic activation resulted in significant renal, 
pulmonary and systemic vasoconstriction without corona~ vasoconstriction. 
These results demonstrate unequivocally an important invivo vasoconstrictor 
role for the ET-B receptor in the systemic, pulmonary and renal circulations. 
~ Inhib|tion of Endothelial-Derived Fsofor Relaxing 
Enhances the Coronary Vasoconstriction to 
Endofhelin-B Activation 
Charles R. Carman, John C. Bumett Jr., Amir Lerman. Mayo Clinic, 
Rochester, MN 
ET, a corona~ vasoconstrictor, mediates its activity through two specific ETA 
and ET-B receptors. Studies demonstrated that ET-B receptorS are located 
on both the endothelium and vascular smooth muscle celts and may mediate 
vasodJ/atation via the re/ease of endothelium-dedved relaxing factor (EDRF] 
offsets direct vasoconstrictive activity. The current stUdy was design to test 
the hypothesis that the inhibition of EDRF may enhance the coronazy vase- 
constriction to specific ET-B receptor stimulation with sarafetoxin, aselective 
ET-B receptor agonist. Therefore, sarafutoxin (Group 1, n = 5), and Sarefo- 
toxin + NG-monomethyl-L-arginine (LNMMA, 50/~g/kg/min). (Group 2, n = 
5) were infused into the left circumflex coronary artery, in the anesthetized 
dog, No difference in hemodynamics and comnmy blood flow (CBF), core- 
nan/vascular esistance (CVR) and coronary artery diameter (CAD) were 
observed at baseline. CBF, CVR and CAD were determined at baseline and 
during inlusions and were calculated as % change (A) from baseline. 
Sara~otoxin Sarafotoxin + LNMMA ' " 
%'& CBF --7 4- 3 -28 4- 7* 
% ~ CVR 12:E8 674-24" 
% ,'t CAD -1.S 4- 0.7 02±0.2 
*p < 0.05 between Groups. 
This study demonstrates that the inh~on of EDRF enhances the coronary 
vaseconstdction to sarafotoxin which occurred predominantly at the level 
of the coronary microcircutation. This study suggests that ET-B mediated 
release of EDRF anoVor basal produ~on of EDRF offset the direct comnsxy 
vasoconstrictive action of the ET-B receptom in the coronary mic~ocirculation. 
~ Effeof of Nitric Oxide on the Pulmonary Vascular 
Pressure-Flow Relationship in a Canine Model of 
Thrombofytio Pulmonary Hypertension 
I=. H. Shiffman, R. M. Prewitt, U. Schick, J. Duces. Health Sciences CentTe, 
University of Manitoba, Winnipeg, Manitoba, Canada 
Nitric oxide (NO) has been shown to be effective in reducing pulmonary aden/ 
pressure in many forms of pulmonary hypertension. While the inlracallular 
mechanism of action is known, the pulmonary hemodynamic effects are 
not fully elucidated. This study examined the effects of inhaled NO on the 
pulmonary vascular pressure-flow (P-Q) relationship in a canine model of 
pulmonary embolism. According to P-Q theory, the slope of the P-Q plot 
defines the mctementa~ vascular resiefanco (unit pressure change per unit 
change in flow) and the extrapolated pressure intercept defines the affect~e 
vascular outflow pressure. Six dogs were embolized with autologous blood 
clot to create pulmonary hypertension complicated by a low cardiac output 
state. To define the P-Q plot, multiple mean pulmonary artery pressure (PAP) 
vs cardiac output (CO) coordinates were obtained pre and pest embolization, 
and before, during and alter treatment with nitric oxide (180-200 ppm). 
The PAP-CO coordinates were obtained by varying flow through systemic 
artedoveneus fistulas. Embolization increased PAP (14.8 :E 1.2 to 34.6 :E 
4.6; p < 0.001 )and decreased CO (3.45 ± 0.63 to 2.25:1: 0.43; p < 0.05). All 
PAP-CO relationships were well descnl)ed by a linear equation (mean rvalue 
0.921 :E 0.029). Both the slope and intercept of the PAP-CO plot increased 
with embelization, (1A1 ± 0.09 to 3.51 :k 1.22; p < 0.05 and 9.9 + 1.1 to 
28.0 ± 6.5; p < 0.005 respectively). NO significantly improved pulmonary 
hemodynamics. The intercept of the PAP-CO plot decreased from the ~nitial 
control of 28.0 mmHg to 22.5 mmHg (p < g.05), and Iollowing discontinuation 
of the NO, increased to 26.2 mmHg Co < 0.05). The slope was not affected. 
Furthermore, NO did not affect systemic bemedynarnics. In this model of 
pulmonaJ7 embolism, the increase in PAP is predominantly explained by 
an increase in the extrapolated pressure intercept (P0 and NO selectively 
improved pulmonary hemodynamics bydecreesing Pc. C_~ndusian: Based on 
previous work, it is most likely that the decrease in Pj represents a localized 
decrease in pulmonary vascular tone upstream from the capillary bed. 
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~ Relation Between Myocardial Damage and 
Noradrenergl© Aotivlties in the Central and 
Peripheral Nervous Systems in Patients W'dh 
Subarachnoid Hemorrhage 
Shinichiro Yamamoto, Takashi Masuda, Narihisa Matsuyama, 
KiyotaR~ Sate, Koh-ichire Okuhara, Chiharu Noda, K~zuko Murakami, 
Takashi Ohwada. Kitasato Universily, Sagamihara, Kanagawa, JAPAN 
To dadly the rata ol noradrenergis ast~ties of the central and penphoral 
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nervous ystems in the occurrence of myocardial damage following aneurys- 
mal subarechnoid hemorrhage (SAH), we measured serum levels el MS-CK 
(MB), myosin light chain (Me) and trcponin T (Tn), and plasma concoctra- 
t~ons of coradranaline (NA), adrenaline (ADR) and MHPG as an indicator of 
NA activity of the brain in 720 SAH patients who admitted within 24 hours of 
the onset. Eighty patients had elevated levels of MB, Mn orTn that indicated 
myocardial damage (group A) and were compared to 640 patients without 
myocardial damage (group B). Myocardial damage in group A was related to 
the initial level of neurological severity, as assessed by WFNS grade, but was 
not related to the amount of subarachnoid blood visualized on the computed 
tomogram. There was no sigffdicant d~erence between two groups in b~oed 
pressure. Heart rate was significantly higher in group A than in group B (93 
29 vs 85 ± 20/mini p < 0.01). Plasma concentrations of NA, ADR and 
MHPG were significantly higher in group A than in group B (2316 + 4778 vs 
828 ~- 736 ~g/ml; p < 0.01,752 4-1129 vs 362 • 512 pg/ml; p < 0.01, and 23 
4- 26 vs 9 4- 6 ng/ml; p < 0.01, respectively), Inall patients, serum MB level 
had positive correlation with plasma NA, ADR and MHPG (r = 0.48, r = 0.50 
and r = 0.53, respectively), and Tn level also had positive correlation with 
plasma NA, ADR and MHPG (r = 0.75, r = 0.74 and r = 0,72, respect~valy). 
These results suggest hat noradrenergic activities in the central and pe- 
ripheral nervous ystems play an important role in the occurrence of myocar- 
dial damag~ ssociated with SAH. 
~ Three-Dimensional Measurements of Volume 
Plaques in the Arteria Carotis and the Arteria 
Femoralis 
C. Ebner, W. Tkalec, H.J, Nessec St. Elizabeth Hospital, Unz, Austria 
Non invasive plaque quantification and assesment of progression are main 
goals in ultrasound iagnostics. 
In 34 patients 114 ultrasound investigations were performed by three dif- 
ferent methods, using a 5 MHz linear array (Vingmed Masters ;~ade~). The 
probe was combined with a three dimensional (3D) reconsi,"uclion facility 
(TOMTEC). The documentation was realized by ECG- and breath-t~ggered 
6toting of the images in a transversal view. For optimal visualization an angle 
correction up 4- 30 degrees was possible. The plaque volume was cs:cu!~tsd 
based on sadal transversal sections by manual tracing of the plaque outlines. 
Each plaque was measured in one chosen mode by two experienced sono- 
graphers and once in another mode by the first sonographer. To validate the 
method we examined an in vitro plaque model. 
Results:We measured 39 subsignificant plaques (< 400 lumen reduction) 
in 29 carotid and 9 femoral arteries, A mean plaque volume of 77.5 cmm 
in examination I, 83.5 cmm in examination II, and 78.3 cmm in examination 
III was calculated. The interobservervadability ranged from 0.07 to 20.6 (m 
6.5)%, the intraobservervadability from 0.02 to 18.7 (m 8.1)%. The in vitro 
model with a defined volume of 1000 cmm was calculated between 931 
and 1106 (m 1044) cram with a mean interebservervadability of 6,3P/o. 
Additionally three dimensional reconstructions have been performed. 
In conclusion three dimensional plaque volume measurement isa promis- 
ing method for early detection of plaque progression in consecutive scans. 
Additional 3O reconstructions render a batter conception of the plaque ex- 
tention. 
~ Myocardial Involvement in Takayaau Arterltls 
K,K. Talwar, A.K. Goal, A. Saxena, D. Prabhakaran, P. Chopra, S. Sharma. 
Cardiothorac[c Sc[ances Center, All India Institute of Medical Sciences, New 
Delhi (INDIA) 
Congestive heart failure (CHF) is not an uncommon presentation i Takayasu 
artadtls (TA), To understand the pathogenesis of CHF in this disease we 
carded out endomyocerdial biopsy (EMB) in 85 patients (males 29, females 
56, age 2 to 42 yra) with angiographiceliy proven TA. The EMB was done 
form RV using cordis bioptome and 3 to 5 pieces were taken in 10% formalin 
for Nstologlcal examinatien. 
Myocardial involvement was present in 65 (76.~,%) and included fo- 
cal/dilfuse myocarditis in 26 (30,5%), myofiber hypertrophy in 39 (45.8('/o) 
and endocardlal thickening in 9 (10,6%). 39/65 (60%) with histological my- 
ocardial involvement had CHF. In 10 of these there was no associated 
hypettension or valvular involvement to account for CHF. Di6tdbution of my- 
ecardlal involvement did not show any predilection for the various types of TA 
as defined by Uano et al, Immunosupprossive therapy resulted in regression 
of myocerditis on repeat EMB and improvement ofCHF. 
Conclusion: Myocardial involvement appears to be common in TA and EMB 
should be done in all patients with CHF to detect undedying myocardifis. In 
view of its therapeutic importance itshould be incorporated in classification 
of TA. 
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~ Pulmonary Clearance of Circulating Endothelin-1 
in Dogs in Vivo: Exclusive Role of ETa Receptors 
Jocelyn Dupuis, Cad A, Gorssky, Alain Foumier. Montreal Heart Institute 
and INRS-Santd, Montreal, Canada 
The pulmonary circulation plays an important role in the removal of circulat- 
ing endothalin-1 (ET-1). Plasma ST-1 levals me increased in heart failure, 
purmcnary hypertension and congenital heart diseases and may partly result 
from reduced pulmonary clearance of this vasoactive peptide. We studied the 
rote of the ETA and ETa receptors fn the pulmonary clearance of [125]-I.ET-1 
in anesthetized ogs using the multiple indicator dilution technique. Experi- 
ments were carded out before and 5 minutes after intrapulmonary injection 
of specific antagonists for the ETA (BQ123) and ETa receptors (BQ788) 
(approximately 1 #mot per i~lion), 
Control BQ123 Control BQ788 
N=S N=6 
Flow (ml/s) 42 ± 10 42 ± 9 56 4- 26 51 ± 24 
HR (beats/rain) 160=1:20 169~:23 166±7 167±5 
MAP (mmHg) 149:1:23 143± 17 141 .;- 13 140:t: 13 
MPAP (mmHg) 14 ± 2.7 14 :i: 2 20 4- 2 20 + 3 
Ctaman~'e (%) 36 ~ 4.2 34 ~ 6A 33 ~: 7 0 ± 2* 
Kseq (s -~ ) 0.050 :k 0.009 0.047±0.014 0.052"+-0.019 - 
*p < 0.01 vs control; MAP = mean artadalpressure;MPAP = mean pulmonary artery pres. 
sure; Kseq = pulmonary sequestration rata constant for ET-1. 
ETA and ETs antagonists had no effect on systemic and pulmonary heine- 
dynamics. Pulmonary clearance was unaffected by BQ123 but was com- 
pletely abolished by SQ788 (from 33% to ~) ,  indicating that ST-1 is cleared 
exclusively by ETa receptors. 
Conclusions: The ETa receptor is exclusively responsible for pulmonary 
ST-1 clearance in vivo. Alterations or downregulation of this receptor may 
contribute to the increase in circulating ET-1 levels found in certain patho- 
logic conditions. These findings may also explain the observed rebound 
phenomenon after withdrawal of non-specific ETA and ETa antagonists. 
~ Captopril Reduces Endothelin,1 Release From 
Human Urnbllicel Vein Endothelial Cells by 
Reduction of Angiotensin II Synthesis 
Jan K~.hler, Stephan Baldt:s, Till v.Varendodf, Ralf K0ster, Wolfram Ten'as, 
Christien W. Hamm, Thomas Meinertz. Department of Cardiology, 
University Hospital Eppendoff, Hamburg, Germany 
Angiotensin converting enzyme (ACE) inhibitors reduce AT if synthesis and 
increase bradykinin (BK) levels. Angiotensin II (AT II) stimulates the synthesis 
of endothelin-1 (ET-1). Elevated SK levels augment he release of nitric oxide 
that is thought o be a major functional antagonist of ET-1 and decreases 
its synthesis. This study was conducted to determine whether the reduction 
of AT II induced by captopdl has an effect on the release of immunoreac- 
tive ET-1 (irET-1) from human umbilical vein endothelial cells. The effect of 
captcpdl on irET-1 release was compared to that of the AT1/AT2 receptor 
antagonists 106artan and CGP42112. Furthermore the effect of nitdc oxide on 
irET-1 release was investigated. Results: Captopfil reduced irET-1 release 
of cultured endothelial cells in a time and concentration dependent manner 
(60 + 8 fmof/10 s coils vs control 85 ± 6 fmol/10 s cells after 72 hou,~, p < 
0.05). The ATt/AT2 receptor antagonists Iosartan and CGP421t2 reduced 
irET-1 release in a concentration dependent and additive fashion (losartan 
46 ± 2Imol/10 s ceils, CGP42112 47 ~ 3 fmof/105 cells, Iosartan and COP 40 
± 3 tmolll0 s cells vs contre~ 50 ~ 4 fro01/10 s ceils, p < 0,05). The reduction 
of irET-1 release by captopril was not augmented by addition of Iosartan 
and CGP42112. The inhibition of nitdc oxide synthesis by NO-monomathyl 
L-arginine resulted in a minor increase in irET-1 levels. The increase of nitric 
oxide levels by 6ydnonimins had no influence on irET-1 release. Thus, it is 
concluded that ceptopdl reduces endothelin-1 release of cultured endothe- 
lial cells predominantly by decreasing angiotensin II synthesis but not by 
stimulation of the bradykinin/nitric oxide pathway, 
